The pharmaceutical sector has welcomed the announcement by the Department of Health that the NHS rebate rate for newer medicines will fall to 14.5 per cent next year, down from
All posts tagged in healthcare investment
9Articles
A breakthrough in the battle against Alzheimer’s disease may be on the horizon after promising trial results revealed the potential of an innovative drug developed by Roche. Trontinemab has delivered
Recent clinical trials have unveiled a significant breakthrough in the potential application of weight-loss medication Semaglutide, marketed as Wegovy, in reducing alcohol consumption. The groundbreaking study demonstrated a remarkable 40%
British care homes witnessed unprecedented transaction levels in 2024, with American investors leading the charge in one of the few property sectors still delivering robust rental growth. Data from property
A landmark research initiative analysing blood proteins could catalyse significant advancements in disease treatment and prevention, presenting substantial opportunities for healthcare sector investors. The extensive UK-based study, backed by 14
The deteriorating state of NHS hospital buildings across England has reached a critical point, posing severe risks to patient and staff safety through potential fires, floods, and electrical failures. Internal
The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage
Recent breakthrough research from Denmark’s Aarhus University has sparked significant market interest in the pharmaceutical sector, particularly concerning exercise mimetics. The discovery of LaKe, a compound purported to replicate the
A concerning trend in cancer diagnoses among young adults has sparked a significant £20 million global research initiative. Data from the UK reveals cancer cases in individuals under 50 are
